Protein misfolding and amyloid fibril deposition may lead to several neurodegenerative disorders like Alzheimer's, Parkinson's, Huntington's, and similar amyloid polyneuropathies. Inhibition of fibril formation and disaggregation of mature fibrils by some chemical compounds could be a therapeutic approach toward such chronic diseases. In this study, we synthesized a series of novel steroidal pyrazolines and tested the effects of the series on the in vitro inhibition of human lysozyme aggregation. The effect of synthesized steroidal compounds on the kinetics of protein aggregation inhibition was elucidated by Tryptophan (Trp), 8-anilino-1-naphthalenesulfonic acid (ANS), and Congo red (CR) spectral analysis. Further, we examined that the ring closure reaction in the later step produced a mixture of two steroidal pyrazoline epimers that could only be separated in their acetylated form. The (5’S)-3β-acetoxy steroidal pyrazolines (5a-i) were found as the major product and their structures were examined using NMR techniques. The efficacy of various acid catalysts to catalyze the condensation reaction was also evaluated to obtain better yield in lesser time. In addition, molecular docking studies were also performed to understand the receptor-ligand binding interactions.